Sinovac Biotech Ltd opened lower at -, compared with its previous close of $6.47. In the last trading session on 19 Oct 2026, the stock traded between - and -. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 1 year ago in Sinovac Biotech Ltd is now worth
$ 100.00
Giving a profit of
$ 0.00 (0.00%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+$0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
$6.47
Volume
-
1W Return
0.00%
1M Return
0.00%
3M Return
0.00%
6M Return
0.00%
1Y Return
0.00%
Fundamentals
Market Cap ($ Mn)
-
PE Ratio
19.03
PB Ratio
1.82
PEG Ratio
1.07
ROE
-2.95%
ROCE
-1.86%
EPS (TTM)
$1.09
Investment Returns
1 Week
0.00%
1 Month
0.00%
3 Months
0.00%
6 Months
0.00%
9 Months
0.00%
Financials
Quarterly
All values in $ Mn
64.3
Sep 19
81.1
Dec 19
15.4
Mar 20
52.3
Jun 20
115.5
Sep 20
327.5
Dec 20
Updates
17Aug
Sinovac Biotech H1 Results: Sales Rise 13% YoY, EPS Turns To Loss
Sinovac Biotech's H1 results show a stark contrast between top-line growth and bottom-line performance. Sales increased by 12.9% to $147.079 million, yet earnings per share plummeted by 1500% to a loss of $(0.84) from $0.06. This divergence suggests rising cost pressures outpaced revenue generation.
2mo ago
15Jun
Sinovac Biotech regains compliance with Nasdaq Global Market listing requirements
Sinovac Biotech Ltd. regained compliance with Nasdaq Global Market listing requirements after filing its annual report on Form 20-F for the year ended December 31, 2025. The company received a notification letter on June 10, 2026, confirming compliance with Listing Rule 5250(c)(1). However, Sinovac remains under a Mandatory Panel Monitor until May 20, 2027.
